Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-23, Stock:ABBV, The news for the past five days is as follows:
2019-07-16: NEWS1: AbbVie Buys Allergan for $63 Billion.NEWS2: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS3: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS4: Commit To Purchase AbbVie At $40, Earn 3.2% Using Options.NEWS5: Commit To Purchase AbbVie At $40, Earn 3.2% Using Options.NEWS6: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS7: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS8: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS9: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS10: Allergan Stock Won’t Rise Much More, Analyst Says, in Looking at Deal With AbbVie.
2019-07-17: NEWS1: AbbVie (ABBV) is an Incredible Growth Stock: 3 Reasons Why.NEWS2: AbbVie (ABBV) is an Incredible Growth Stock: 3 Reasons Why.NEWS3: AbbVie (ABBV) Upgraded to Buy: Here's What You Should Know.NEWS4: AbbVie (ABBV) Upgraded to Buy: Here's What You Should Know.NEWS5: Health care 'Cadillac Tax' repeal bill up for vote Wednesday.NEWS6: Should Value Investors Buy AbbVie (ABBV) Stock?.NEWS7: AbbVie (ABBV) Upgraded to Buy: Here's What You Should Know.NEWS8: AbbVie (ABBV) is an Incredible Growth Stock: 3 Reasons Why.
2019-07-18: NEWS1: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS2: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS3: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS4: Novartis (NVS) Beats on Q2 Earnings & Sales, Raises Guidance.NEWS5: Novartis (NVS) Beats on Q2 Earnings & Sales, Raises Guidance.NEWS6: AC Immune Initiates Phase I Study for Alzheimer's Disease.NEWS7: AC Immune Initiates Phase I Study for Alzheimer's Disease.NEWS8: Novartis's Pure Play in Pharma Works, for Now.NEWS9: AC Immune Initiates Phase I Study for Alzheimer's Disease.NEWS10: Novartis (NVS) Beats on Q2 Earnings & Sales, Raises Guidance.NEWS11: 3 Top Dividend Stocks With Yields Over 4%.
2019-07-19: NEWS1: The 3 Top Stocks for Dividends Every Calendar Month.NEWS2: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS3: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS4: IYH, ABBV, CI, BDX: Large Outflows Detected at ETF.NEWS5: IYH, ABBV, CI, BDX: Large Outflows Detected at ETF.NEWS6: AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?.NEWS7: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.
2019-07-22: NEWS1: AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know.NEWS2: Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy.NEWS3: Can Allergan (AGN) Keep the Earnings Streak Alive in Q2?.NEWS4: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS5: Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect.NEWS6: The Parnassus Fund Exits Mattel, Sells Alphabet.

Answer: Decrease